The two ATM protein‐truncating mutations we identified for the first time in breast cancer families, had already been reported as either homozygous or compound heterozygous alterations in Ataxia‐Telangiectasia patients 33, 34, but their impact on cancer risk was not previously described. The gene discussed is ATM; the disease is breast carcinoma.